Table 2 Characteristics of the patients according to rate of normalization of prothrombin time, and warfarin therapy

188

14

202

136(72)

11(79)

147(73)

n.s.^‡

69.1(± 10.8)

(36–89)

73.4(± 13.2)

(48–93)

69.4(± 11.0)

(36–93)

0.16

0.49

29.2(± 5.5)

(17.1–55.1)

29.0(± 4.3)

(22.2–40.1)

29.2(± 5.4)

(17.1–55.1)

n.s

29.7(± 12.3)

(6.25–77)

23.2(± 13.7)

(8.75–57.5)

29.3(± 12.4)

(6.25–77)

0.06

0.20

2.6(± 0.5) (2.0–4.2)

3.2(± 0.6) (2.1–4.3)

2.7(± 0.5) (2.0–4.3)

0.0004

0.0021

-6.1(± 0.5) (-8 – -5)

-6.1(± 0.3) (-7 – -6)

-6.1(± 0.5)

n.s.

104(± 34) (49–336)

120(± 41) (65–196)

105(± 35) (49–336)

0.09

0.40

7(3.7)

1(7.1)

8(4.0)

n.s.

1.5(± 1.3) (-1 – 5)

1.4(± 1.4) (0–4)

1.5(± 1.3) (-1 – 5)

n.s.

7 (± 3) (0–14)

8 (± 3) (4–16)

7 (± 3) (0–16)

n.s.

29(15)

2(14)

31(15)

n.s.

21(11)

2(14)

23(11)

n.s.